Innovation and Change in Pharmaceutical Industry

Achilladelis and Antonakis conducted a historical study of the dynamics and tendencies of technological innovation in the pharmaceutical industry. From this standpoint, pursuing increase in market share, major pharma companies undertake mergers and acquisitions. As the majority of specialists points out, particularly mergers and acquisitions are considered to be essential ways to obtain innovation capabilities and assuming control levers of any major technological changes within biotech industry. For instance, in the beginning of 90s, Swiss pharmaceutical giant Hoffmann-La Roche after Read more

Bacon, Freud, Mehta, Souza — Human figure in the shadow II War and India’s partition

India’s emerging muscle in global business arena is widely recognised and increasingly respected. It is said that art and economics feed each other. The years of economic sluggishness also reflected in the tough time for Indian artists economically. There were artists with finest expressions who struggled to keep their bodies but it must be said they did not allow their soul—their art—to attrition. To the long list of artists who fought their battle for material survival the likes of M. F. Hussain and Nikhil Biswas should be put in the forefront. While Hussain painted cinema Read more

Innovation in Pharmaceutical Industry

One of the biotechs was Repligen, a Cambridge, Massachusetts, firm (founded in 1981) that specialized in efforts to develop treatments for cancer and inflammation, as well as AIDS. Typical in several regards of the new pattern of R&D was the experience of the Merck Research Laboratories (MRL). While pursuing in-house research, the firm also worked with two biotech companies on alternative approaches to HIV prevention with a vaccine or treatment. Later, Merck collaborated with MedImmune, Inc., a Maryland biotech, in an attempt to use that firm’s monoclonal antibodies as a means of Read more